LISA GAVOSTO: Open Payments
NPI 1174853923 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,285 in 110 payments from 32 companies in 2025. Trend: 2023 $4,124 · 2024 $3,524 · 2025 $2,285
Food & beverage: $2,242Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $250 |
| Corcept Therapeutics | 12 | $209 |
| RECORDATI_RARE_DISEASES_INC. | 8 | $153 |
| Medtronic, Inc. | 5 | $147 |
| Ascendis Pharma Endocrinology Inc | 6 | $145 |
| Amgen Inc. | 9 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $125 |
| Neurocrine BioSciences, Inc. | 4 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $107 |
| Xeris Pharmaceuticals, Inc. | 4 | $81 |
Products named: Korlym, Ozempic, ISTURISA, Yorvipath, Kerendia, CRENESSITY, EVENITY, MINIMED 780G.
Industry payments across FL — which companies pay providers there.
